Hers vs Medro
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Mainstream telehealth GLP-1 access.
- semaglutide
- From $199/molowest dose rung
- tirzepatide
- $299/mobrand-name
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Before enrolling
Limited public information on program details
Desk Score
Compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.
- semaglutide
- $199/mo
- tirzepatide
- $299/mo
Before enrolling
Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
Our review of Hers gives it 76/100 (C), while our review of Medro gives it 71/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
76/100
C
71/100
C
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Hers | Medro |
|---|---|---|
| Semaglutide | From $199/molowest dose rungFull plan terms$199/mo (starting dose, compounded) | $199/moFull plan terms$199/mo (compounded) |
| Tirzepatide | $299/mobrand-nameFull plan terms$299/mo (starting dose, plus a separate fee, brand-name) | $299/moFull plan terms$299/mo (compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Brand-name option listed | Brand-name option listed |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | Mainstream telehealth GLP-1 access. | Compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states. |
| Desk Score | 76/100C | 71/100C |
The verdict
Desk pick — HersHers has the higher Desk Score, but Medro may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Mainstream telehealth GLP-1 access.
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Hers
- CoreAge Rx vs Medro
- Eden vs Hers
- Eden vs Medro
- Hers vs Vytora Health
- Medro vs Vytora Health
Or see the full comparison hub and the complete ranking.